Press "Enter" to skip to content

It has been announced that the Pfizer / BioNTech vaccine is effective against the Brazilian mutation of the corona virus – Health News


According to the results of the laboratory study published in the New England Journal of Medicine, the antibodies created by the 95 percent effective mRNA vaccine managed to neutralize the mutated corona virus.

In a study conducted by the Texas Medical School Hospital and the researchers of the two companies that developed the vaccine, snow samples taken from people with the Pfizer / BioNtech vaccine were infected with a genetically modified corona virus with the same characteristics as the P1 variant.

THE EFFECT OF THE VACCINE IS THE SAME LEVEL TO THE ORIGINAL VERSION OF THE VIRUS

The scientists reported that the ability of the vaccine-generated antibodies to neutralize the virus was almost identical to that of the virus’s original virus.

However, the P1 variant that originated in Brazil has mutations that occur in the spike protein of the corona virus. Since vaccines work by targeting the spike protein, changes in this protein are critical.

Pfizer and BioNTech previously announced that the vaccine was effective against mutations in the UK and South Africa, but it was stated that protective antibodies against the South African variant fell by two-thirds.

Speaking about the research, Pei-Yong Shi, an expert at the University of Texas, noted that the BionTech / Pfizer vaccine is also possible to protect against the variant. Pei-Yong Shi continued his explanation with the following words: We do not know the minimum neutralization limit. I can say that the immune response created by the vaccine is well above the level required to provide protection ”.

P1 VARIANT TAKES SOUTHERN AMERICA

On the other hand, the P.1 variant detected in Brazil deeply affects South American countries. In the country, which broke a daily loss of life record with approximately 2,000 deaths in the past days, researchers stated that the new mutation was effective in this, and that the mutation carried 10 times more viral load than other variants, and was more common in people in their 30s and 40s and without health problems. . In particular, it was stated that the capacities of the hospitals in Peru were completely filled and they had to choose patients for the vacated beds, and if the vaccination did not accelerate, it was stated that the whole of South America was in danger of being infected with the P.1 variant.

CORONA VIRUS PARTY AT THE HOTEL (ARCHIVE)

Download the NTV application, be informed about the developments


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *